Related Experiment Video
Updated: Nov 2, 2025
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.9K
Molecular alterations in pancreatic tumors
Michela Visani1, Giorgia Acquaviva1, Antonio De Leo1
1Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna-Molecular Diagnostic Unit, Azienda USL di Bologna, Bologna 40138, Italy.
World Journal of Gastroenterology
|June 17, 2021
Summary
Genetic alterations in pancreatic tumors involve oncogenes, tumor suppressors, and DNA repair genes. Molecular testing, including next-generation sequencing, aids in diagnosing pancreatic lesions and characterizing specific tumor types.
Area of Science:
- Oncology
- Genetics
- Gastroenterology
Background:
- Pancreatic tumors exhibit genetic alterations including oncogene activation, tumor suppressor gene inactivation, and DNA repair gene dysfunction.
- Endoscopic ultrasound-guided fine-needle aspiration improves diagnosis but challenges remain for inconclusive specimens.
- Molecular testing offers potential solutions for ambiguous pancreatic lesion diagnoses.
Purpose of the Study:
- To review the primary molecular alterations identified in various pancreatic tumors.
- To highlight the utility of multi-gene analysis in characterizing pancreatic neoplasms.
Main Methods:
- Literature review summarizing key findings on genetic alterations in pancreatic tumors.
- Discussion of next-generation sequencing as a tool for molecular characterization.
Main Results:
- Pancreatic tumors are characterized by specific genetic profiles.
- Distinct molecular alterations define different pancreatic tumor types, such as pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms.
Conclusions:
- Understanding molecular alterations is crucial for diagnosing and managing pancreatic tumors.
- Advanced molecular techniques like next-generation sequencing enhance the characterization of pancreatic neoplasms.
